BMEA ▲ +7.1% - Biomea Fusion, Inc.
$BMEA - Biomea Fusion to Announce Phase I Results for BMF-650, Its Next-Generation Oral Small-Molecule GLP-1 Receptor Agonist
12-OCT-2026 04:30 PM ET
Share this post
More filings for $BMEA
BMEA ▼ -13.5% - Biomea Fusion, Inc.Sep 23, 2026BMEA ▼ -21.1% - Biomea Fusion, Inc.Sep 22, 2026BMEA ▼ -0.5% - Biomea Fusion, Inc.Sep 3, 2026
View full $BMEA filing history →💬 Comments
Loading comments…
Leave a comment